Loading clinical trials...
Loading clinical trials...
A Phase I Randomized, Open-label, 3-arm Parallel-design Study to Determine the Effect of Multiple-dose Gemfibrozil or Itraconazole on the Pharmacokinetics, Safety and Tolerability of Single-dose MDV3100 (ASP9785) in Healthy Male Subjects
Conditions
Interventions
MDV3100
Gemfibrozil
+1 more
Locations
1
France
SGS
Paris, France
Start Date
August 1, 2011
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
August 1, 2013
NCT07052162
NCT06342713
NCT06014515
NCT04961593
NCT07219940
NCT06426836
Lead Sponsor
Astellas Pharma Europe B.V.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions